Pleural fluid analysis for evaluating pleural effusions

Current Respiratory Medicine Reviews

Volumn 4, Issue 3, 2008, Pages 217-225

  Porcel, José M ^a   Light, Richard W ^b  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Exudates; Malignant pleural disease; Pleural effusion; Pleural infection

Indexed keywords

ADENOSINE DEAMINASE; BRAIN NATRIURETIC PEPTIDE; GAMMA INTERFERON; GLUCOSE; LACTATE DEHYDROGENASE; NATRIURETIC FACTOR; PROTEIN;

BACTERIUM CULTURE; CELL COUNT; CHYLOTHORAX; CLINICAL CHEMISTRY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PANCREAS DISEASE; PH; PLEURA CANCER; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PLEURA MESOTHELIOMA; PLEURISY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; THORACOCENTESIS; TUBERCULOUS PLEURISY;

EID: 53649110878     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339808785161369     Document Type: Review

References (88)

1. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician; 2006; 73: 1211-20.
2. Light RW. Pleural Diseases, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007.
3. Sahn SA. Pleural effusions of extravascular origin. Clin Chest Med 2006; 27: 285-308.
4. Porcel JM, Madroñero AB, Pardina M, Vives M, Esquerda A, Light RW. Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients. Respirology 2007; 12: 234-9.
5. Porcel-Pérez JM, Vives-Soto M, Esquerda-Serrano A, Jover-Sáenz A. Cuttoff values of biochemical tests on pleural fluid: their usefulness in defferential of 1,040 patients with pleural effusion. An Med Interna 2004; 21: 113-7.
6. Porcel JM, Light RW. Effusions from vascular causes. In: Light RW, Gary Lee YC, eds. Textbook of Pleural Diseases, 2nd ed. London: Hodder Arnold 2008; pp. 397-408.
7. Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002; 122: 1913-7.
8. Heffner JE. Discriminating between transudates and exudates. Clin Chest Med 2006; 27: 241-52.
9. Jenkinson F, Murphy MJ. Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results. Ann Clin Biochem 2007; 44: 471-73.
10. Porcel JM, Peña JM, Vicente de Vera C, Esquerda A. Reappraisal of the standard method (Light's criteria) for identifying pleural exudates. Med Clin (Barc) 2006; 126: 211-3.
11. Porcel JM. Effusions from cardiac failure. Int Pleural Newsl 2007; 5: 16-7.
12. Romero-Candeira S, Hernández L. The separation of transudates and exudates with particular reference to the protein gradient. Curr Opin Pulm Med 2004; 10: 294-8.
13. Porcel JM, Peña JM, Vicente de Vera MC, Esquerda A, Vives M, Light RW. Bayesian analysis using continuous likelihood ratios for identifying pleural exudates. Respir Med 2006; 100: 1960-5.
14. Esquerda A, Trujillano J, López de Ullibarri I, Bielsa S, Madroñero AB, Porcel JM. Classification tree analysis for the discrimination of pleural exudates and transudates. Clin Chem Lab Med 2007; 45: 82-7.
15. Porcel JM, Salud A. Two rare cases of lymphocytic effusions. Int Pleural Newsl 2003; 1: 13-4.
16. Porcel JM. The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure. Curr Opin Pulm Med 2005; 11: 329-33.
17. Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Höffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28: 144-50.
18. Porcel JM, Chorda J, Cao G, Esquerda A, Ruiz-González A, Vives M. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12: 654-9.
19. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131: 880-9.
20. Goto M, Noguchi Y, Koyama H, Hira K, Shimbo T, Fukui T. Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann Clin Biochem 2003; 40: 374-81.
21. Porcel JM, Vives M, Esquerda A, Ruiz A. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med 2006; 100: 933-7.
22. Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001; 120: 356-61.
23. Porcel JM, Vives M. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2002; 121: 1379-1380.
24. Jiménez Castro D, Díaz Nuevo G, Pérez-Rodríguez E, Light RW. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003; 21: 220-4.
25. Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007; 131: 1133-41.
26. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003; 7: 777-86.
27. Losi M, Bossink A, Codecasa L, et al. for the European Tuberculosis Network TBNET. Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007; 30: 1173-9.
28. Sahn SA. Clinical value of pleural fluid pH. Int Pleural Newsl 2003; 1: 4-5.
29. García-Pachon E, Romero S. Urinothorax: a new approach. Curr Opin Pulm Med 2006; 12: 259-63.
30. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995; 151: 1700-8.
31. Jiménez Castro D, Díaz Nuevo G, Sueiro A, Muriel A, Pérez-Rodríguez E, Light RW. Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration 2005; 72: 357-64.
32. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118: 1158-71.
33. Davies CW, Gleeson FV, Davies RJ. Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax 2003; 58 Suppl 2: ii18-28.
34. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006; 3: 75-80.
35. Curry L, Stanton A. A caveat in empyema diagnosis. Int Pleural Newsl 2008; 6: 4.
36. Maskell NA, Gleeson FV, Darby M, Davies RJ. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest 2004; 126: 2022-4.
37. Vives M, Porcel JM, Gázquez I, Pérez B, Rubio M. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions. Respiration 2000; 67: 433-8.
38. Alegre J, Jufresa J, Segura R, et al. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 2002; 19: 320-5.
39. Alemán C, Alegre J, Segura RM, et al. Polymorphonuclear elastase in the early diagnosis of complicated pyogenic pleural effusions. Respiration 2003; 70: 462-7.
40. Porcel JM, Vives M, Esquerda A. Tumour necrosis factor-α in pleural fluid: a marker of complicated parapneumonic effusions. Chest 2004; 125: 160-4.
41. Porcel JM, Galindo C, Esquerda A, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology 2008; 13: 58-62.
42. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117: 79-86.
43. Bielsa S, Salud A, Martínez M, et al. Prognostic significance of pleural fluid data in patients with malignant effusions. Eur J Intern Med (in press).
44. Rodríguez-Panadero F, López Mejías J. Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 1989; 139: 663-7.
45. Sánchez-Armengol A, Rodríguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993; 104: 1482-5.
46. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest 2000; 117: 87-95.
47. Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126: 1757-63.
48. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J, Yang HB. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008; 63: 35-41.
49. Gu P, Huang G, Chen Y, Zhu C, Yuan J, Sheng S. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and metaanalysis. J Clin Lab Anal 2007; 21: 398-405.
50. Scherpereel A, Lee YC. Biomarkers for mesothelioma. Curr Opin Pulm Med 2007; 13: 339-43.
51. Scherpereel A, Grigoriu B, Conti M, et al. Soluble mesothelinrelated peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 2006; 173: 1155-60.
52. Creaney J, Yeoman D, Naumoff LK, et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007; 62: 569-76.
53. Porcel JM, Ordi-Ros J, Esquerda A, et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007; 16: 25-27.
54. Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80: 867-70.
55. Romero S. Nontraumatic chylothorax. Curr Opin Pulm Med 2000; 6: 287-91.
56. Maskell NA, Butland RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58 Suppl 2: ii8-17.
57. Branca P, Rodriguez RM, Rogers JT, Ayo DS, Moyers JP, Light RW. Routine measurement of pleural fluid amylase is not indicated. Arch Intern Med 2001; 161: 228-32.
58. Raghu MG, Wig JD, Kochhar R, et al. Lung complications in acute pancreatitis. JOP 2007; 8: 177-85.
59. Villena V, Pérez V, Pozo F, et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. Chest 2002; 121: 470-74.
60. Haro-Estarriol M, Casamitjá-Sot MT, Alvarez-Castillo LA, Calderón-López JC, Martínez-Somolinos S, Sebastián-Quetglas F. Utility of amylase levels in malignant pleural effusions. Med Clin (Barc) 2007; 129: 372-4.
61. Barnes TW, Olson EJ, Morgenthaler TI, Edson RS, Decker PA, Ryu JH. Low yield of microbiologic studies on pleural fluid specimens. Chest 2005; 127: 916-21.
62. Tsai TH, Jerng JS, Chen KY, Yu CJ, Yang PC. Community-acquired thoracic empyema in older people. J Am Geriatr Soc 2005; 53: 1203-9.
63. Ozol D, Oktem S, Erdinc E. Complicated parapneumonic effusion and empyema thoracis: microbiologic and therapeutic aspects. Respir Med 2006; 100: 286-91.
64. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174: 817-23.
65. Soriano T, Alegre J, Alemán C, et al. Factors influencing length of hospital stay in patients with bacterial pleural effusion. Respiration 2005; 72: 587-93.
66. Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006; 119: 877-83.
67. Foster S, Maskell N. Bacteriology of complicated parapneumonic effusions. Curr Opin Pulm Med 2007; 13: 319-23.
68. Valdés L, Álvarez D, San José E, et al. Tuberculous pleurisy. Arch Intern Med 1998; 158: 2017-21.
69. Luzze H, Elliott AM, Joloba ML, et al. Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. Int J Tuberc Lung Dis 2001; 5: 746-53.
70. Hasaneen NA, Zaki ME, Shalaby HM, El-Morsi AS. Polymerase chain reaction of pleural biopsy is a rapid and sensitive method for the diagnosis of tuberculous pleural effusion. Chest 2003; 124: 2105-11.
71. Falguera M, López A, Nogués A, Porcel JM, Rubio-Caballero M. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 2002; 122: 2212-6.
72. Porcel JM, Ruiz-González A, Falguera M, et al. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. Chest 2007; 131: 1442-7.
73. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007; 11: 1-196.
74. Pai M, Flores LL, Hubbard A, Riley LW, Colford JM Jr. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 2004; 4: 6.
75. Anie Y, Sumi S, Varghese P, Madhavi LG, Sathish M, Radhakrishnan VV. Diagnostic approaches in patients with tuberculous pleural effusion. Diagn Microbiol Infect Dis 2007; 59: 389-94.
76. Trajman A, Kaisermann C, Luiz RR, et al. Pleural fluid ADA, IgA-ELISA and PCR sensitivities for the diagnosis of pleural tuberculosis. Scand J Clin Lab Invest 2007; 67: 877-84.
77. Yang CS, Lee JS, Lee HM, et al. Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respir Med 2008; 102: 280-6.
78. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003; 9: 254-60.
79. Reechaipichitkul W, Chuesakoolvanich K. Eosinophilic pleural effusion in adults at Srinagarind Hospital. Southeast Asian J Trop Med Public Health 2003; 34: 374-78.
80. Heidecker J, Kaplan A, Sahn SA. Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci 2006; 332: 148-52.
81. Bielsa S, Panadés MJ, Egido R, et al. Accuracy of pleural fluid cytology in malignant effusions. An Med Intern (Madrid) (in press).
82. Czader M, Ali SZ. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions. Diagn Cytopathol 2003; 29: 74-8.
83. Marchevsky AM, Wick MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol 2007; 15: 140-4.
84. King JE, Thatcher N, Pickering CA, Hasleton PS. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006; 48: 223-32.
85. Gasparri R, Leo F, Veronesi G, et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 2006; 106: 271-6.
86. Hirsch FW, Deibert P, Busch H, Löhr GW, Bross KJ. Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay. J Cancer Res Clin Oncol 1991; 117: 217-22.
87. Davidson B, Konstantinovsky S, Nielsen S, et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin Cancer Res 2004; 10: 7335-46.
88. Fiegl M. The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusions. Curr Opin Pulm Med 2005; 11: 313-8.